Compare ClearPoint Neuro Inc (CLPT) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Neurocrine Biosciences Inc — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Neurocrine Biosciences Inc trades at $151.75 (market cap $16.46B). The key difference: Neurocrine Biosciences Inc is far larger — about 36.2× ClearPoint Neuro Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, ClearPoint Neuro Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | NBIX | |
|---|---|---|
Market Cap | $454.21M | $16.46B |
Sector | Health | Health |
52-Week High | $29.60 | $185.50 |
52-Week Low | $8.66 | $123.10 |
Enterprise Value | $488.79M | $16.48B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
